AST 2014 - Cutting Edge of Transplantation


FR03b - Targeting Pro-inflammatory Cytokines to Improve Long-term Allograft Survival


Feb 14, 2014 5:30pm ‐ Feb 14, 2014 6:00pm

Description

Many studies have shown that IL-6 plays a significant role in defining the immune/alloimmune response. New therapies targeting pro-inflammatory cytokines are now available for the treatment of rheumatoid arthritis. Blockade of IL-6, Th17 related and other cytokines may not only decrease the pro-inflammatory response, but more importantly may favor a regulatory T cell response and thus potentially influence long-term allograft survival.

Speaker(s):

  • Terry Strom, MD, Beth Israel Deaconess Medical Center, Harvard Medical School

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content